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Pluripotency can be induced in somatic cells by overexpressing
transcription factors, including POU class 5 homeobox 1 (OCT3/4),
sex determining region Y-box 2 (SOX2), Krüppel-like factor 4
(KLF4), and myelocytomatosis oncogene (c-MYC). However, some
induced pluripotent stem cells (iPSCs) exhibit defective differenti-
ation and inappropriate maintenance of pluripotency features.
Here we show that dynamic regulation of human endogenous
retroviruses (HERVs) is important in the reprogramming process
toward iPSCs, and in re-establishment of differentiation potential.
During reprogramming, OCT3/4, SOX2, and KLF4 transiently
hyperactivated LTR7s—the long-terminal repeats of HERV type-H
(HERV-H)—to levels much higher than in embryonic stem cells by
direct occupation of LTR7 sites genome-wide. Knocking down
LTR7s or long intergenic non-protein coding RNA, regulator of
reprogramming (lincRNA-RoR), a HERV-H–driven long noncoding
RNA, early in reprogramming markedly reduced the efficiency of
iPSC generation. KLF4 and LTR7 expression decreased to levels
comparable with embryonic stem cells once reprogramming was
complete, but failure to resuppress KLF4 and LTR7s resulted in
defective differentiation. We also observed defective differentia-
tion and LTR7 activation when iPSCs had forced expression of
KLF4. However, when aberrantly expressed KLF4 or LTR7s were
suppressed in defective iPSCs, normal differentiation was restored.
Thus, a major mechanism by which OCT3/4, SOX2, and KLF4 pro-
mote human iPSC generation and reestablish potential for differ-
entiation is by dynamically regulating HERV-H LTR7s.
retrotransposon | epigenetics | evolution
Human pluripotent stem cells can be generated through twopaths: (i) embryonic stem cells (ESCs) can be derived from
embryos (1), and (ii) induced pluripotent stem cells (iPSCs) can
be generated from differentiated cells through factor-mediated
reprogramming (2). Most iPSCs are highly similar to ESCs, but
we recently showed that ∼10% of iPSC clones have a differenti-
ation-defective phenotype, such that 20% of cells were un-
differentiated, even after in vitro-directed neural differentiation
(3). These differentiation-defective (DD)-iPSC clones exhibited
high expression levels of ∼10 genes—including abhydrolase do-
main containing 12B (ABHD12B), HERV-H LTR-associating 1
(HHLA1) and chromosome 4 open reading frame 51 (C4ORF51)—
driven by the long-terminal repeats (LTRs) of human endogenous
retroviruses (HERVs).
HERVs constitute ∼8% of the human genome as a result of
their transposon activity, but they can no longer perform trans-
position (4). HERV type-H (HERV-H) transcripts are expressed
in ESCs/iPSCs at higher levels than in differentiated cells (5).
Approximately 80% of the LTRs belonging to the 50 most highly
expressed HERV-H proviruses are occupied by core transcrip-
tion factors involved in pluripotency, including POU class 5
homeobox 1 (OCT3/4), sex determining region Y-box 2 (SOX2),
and NANOG homeobox (NANOG). Furthermore, HERV-H
proviruses are expressed less in some iPSCs than in other iPSCs
and ESCs, suggesting that HERV-H expression may be a ba-
rometer of pluripotency (5). Species-specific transposable ele-
ments, including HERVs, contribute up to 25% of the core
transcription-factor binding sites in mouse and human pluripo-
tent stem cells, wiring new genes into the core regulatory net-
work of pluripotency in each species (6). These observations
suggest that transposable elements may be important deter-
minants of pluripotency. However, little is known about the
roles of HERVs in reprogramming during iPSC generation.
In the present study, we found that during reprogramming of so-
matic cells toward iPSCs,HERV-HLTR7swere transiently activated
to levels much higher than in ESCs, and this transient activation was
required for efficient reprogramming. When reprogramming was
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complete, HERV-H expression decreased to levels comparable with
those in ESCs. However, in DD-iPSC clones, HERV-H LTR7s
remained aberrantly activated, leading to the defective differentia-
tion. Thus, transient hyperactivation of HERVs is important in
reprogramming somatic cells toward pluripotency and establishment
of differentiation potential, revealing a previously unrecognized
mechanism critical to cellular reprogramming technology.
Results
Characteristics of DD-iPSCs.To better understand the nature of DD-
iPSCs, we performed single-cell subcloning with four defective
iPSC lines established using retroviral vectors, such as TKCBV5-6
(7), TIG108-4F3 (3), and TIG118-4F1 (3), and integration-free
episomal vectors, such as 451F3 (8) (Fig. 1A). The subclones were
identical to their parental clones regarding patterns of integrated
retroviral vectors and short tandem repeats (Fig. S1A and Dataset
S1). Based on marker-gene expression and neural differentiation
potential, each DD-iPSC subclone had a normal or DD pheno-
type, whereas all subclones derived from ESCs and normal iPSCs
exhibited a normal phenotype (3, 9) (Fig. 1B and Fig. S1B). The
primary DD subclones derived from TIG108-4F3 DD-iPSCs were
then used to produce secondary subclones, all of which showed the
DD phenotype. Similarly, all normal primary subclones produced
only normal secondary subclones (Fig. 1C). These data demon-
strate that each DD-iPSC parental clone is monoclonal but con-
sists of both DD and normal iPSCs. However, the DD phenotype
is stable once subclones are isolated.
The subcloning experiments allowed us to compare DD-iPSCs
and their normal counterparts under the same genetic background.
Microarray comparison of global gene expression in normal and
DD-iPSC subclones identified 144 marker genes that were enriched
in DD-iPSCs (Fig. 1D and Dataset S2), including the three previous
reported genes ABHD12B, HHLA1, and C4ORF51. We also
identified long intergenic non-protein coding RNA, regulator of
reprogramming (lincRNA-RoR), an HERV-H LTR7-related large
intergenic noncoding RNA (lincRNA), and KLF4 as DD-iPSC
marker genes (3, 10). Of the DD-iPSC markers, 21.5% (31 of 144)
were located within 30 kb downstream of LTR7s. Gene set en-
richment analysis (GSEA) exhibited a significant correlation be-
tween DD-iPSC marker expression and the existence of HERV-H
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Fig. 1. Enrichment of LTR7s in subcloned DD-iPSCs. (A) Summary of single-
cell subcloning. (B) Differentiation potential of primary subclones. Shown
are the percentages of TRA-1-60 (+) cells 14 d after neural induction of each
primary subclone analyzed by flow cytometry. Blue and yellow circles in-
dicate normal and DD-iPSC subclones/parents, respectively. n = 3. Error bars
are SDs. (C) Differentiation potential of secondary subclones. Shown are the
percentages of TRA-1-60 (+) cells 14 d after neural induction of TIG108-4F3-
PS2- and PS17-derived secondary subclones. Blue and yellow circles indicate
normal and DD-iPSC subclones, respectively. n = 3. Error bars are SDs. (D)
Differential expression of genes between normal and DD-iPSCs. MA plot
comparing global gene expression in normal (n = 18) and DD (n = 37) pri-
mary subclones derived from four DD-iPSCs parental clones (TIG108-4F3,
TIG118-4F1, 451F3, and TKCBV5-6). Red and colored dots indicate genes with
significantly higher expression in DD-iPSCs (FC > 2, FDR < 0.05). (E) Correlation
between DD-marker expression and the presence of LTR7 elements. GSEA plot
showing enrichment of LTR7 elements in 144 DD-iPSC markers. DD-iPSC markers
are displayed in order of their fold-changes between normal- (n = 18) and DD-
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Fig. 2. Resemblance of DD-iPSC and partially reprogrammed cells. (A)
Principal component analysis of DD-iPSC marker genes. Comparison of ex-
pression of 144 DD-iPSC marker genes in HDFs (day 0, n = 4), intermediate
reprogrammed cells derived from HDFs induced by OSKM [EGFP (+) cells on
day 3 and TRA-1-60 (+) cells on d7-49, n = 3–4 in each time point], ESCs (n =
4), and normal (N, n = 18) and DD (D, n = 37)-iPSC subclones. The green
arrow indicates the route of reprogramming. (B) Distribution of DD-iPSC
marker gene expression. The box plot shows expression of 144 DD-iPSC
marker genes in microarray data and their distribution in intermediate
reprogrammed cells [EGFP (+) cells on day 3 and TRA-1-60 (+) cells on days
7–49], normal iPSCs, ESCs, and ESC/normal iPSC-derived differentiated
progenies such as EN, ME, and NE, and PSMN. Red and black boxes indicate
the median and quartile, respectively. Post hoc pairwise comparisons were
performed by Tukey’s test (*P < 0.01 vs. day 0). (C) Transcription of DD-iPSC
markers from LTR7 during reprogramming. Expression of ABHD12B, HHLA1,
C4ORF51, lincRNA-RoR, and ACTB in HDFs (day 0), intermediate reprogrammed
cells [EGFP (+) cells on day 3 and TRA-1-60 (+) cells on days 7–49] and iPSCs
were revealed by RNA-seq. Red arrowheads indicate the LTR7 position and
direction in each locus. (D) All TRA-1-60 (+) cells transiently express DD-iPSC
markers. Ct values plotted by single-cell qRT-PCR for ABHD12B, HHLA1,
C4ORF51, and ACTB in intermediate reprogrammed cells (days 0–28 in the x
axis) and ESCs. At least 42 single cells were analyzed for each sample. Red
dots indicate median values. Gray hourglass shapes represent the distribution of
Ct value. Ct 30 indicates undetectable expression, which was indicated by Ct
values >26. (E) Epigenetic statuses of LTR7s in TRA-1-60 (+) cells. The percentages
of CpG methylation (Left) and H3K4me3 statuses (Right) in LTR7s on each locus
including ABHD12B, HHLA1, and C4ORF51 revealed by bisulfite conversion/
pyrosequencing and ChIP-qPCR, respectively. Day 0, HDFs (n = 3); day 20, TRA-1-
60 (+) cells (n = 3); N, normal iPSCs (n = 3); D, DD-iPSCs (n = 3). Error bars are SD.
*P < 0.05 vs. N was calculated by t test. (F) Neural differentiation-defective
phenotype of TRA-1-60 (+) cells during reprogramming. Proportions of TRA-1-60
(+) cells after SFEBq neural inducing culture for 14 d. n = 3. Error bars are SDs.








q-value < 0.01] (Fig. 1E), showing that aberrant activation of
LTR7s is a characteristic feature of the DD phenotype.
Similarity Between DD-iPSCs and Partially Reprogrammed Cells.Next,
we tried to understand why and how LTR7s were aberrantly ac-
tivated in DD-iPSCs. To this end, we examined LTR7 activities
during the course of iPSC generation. We sorted TRA-1-60–positive
(+) reprogrammed cells on various days after retroviral transduction
of OCT3/4, SOX2, KLF4, and myelocytomatosis oncogene (c-
MYC) (subsequently referred to as OSKM) and analyzed their
global gene expression by microarrays (11, 12). Using principle
component analyses (PCA) with the 144 DD-iPSC markers, we
found similarities between DD-iPSC subclones and TRA-1-60 (+)
intermediate reprogrammed cells (Fig. 2A and Fig. S2). During
reprogramming, TRA-1-60 (+) cells showed transiently en-
hanced expression of the DD-iPSC markers (including those
driven by LTR7s), which reached significantly higher levels than
in ESCs and normal iPSCs (Fig. 2B). When ESCs and normal
iPSCs differentiated into endoderm (EN), mesoderm (ME), and
neuroectoderm (NE), the expression of these markers signifi-
cantly decreased. However, expression remained high in primi-
tive streak-like mesendoderm (PSMN) (12). Deep sequencing
of RNA (RNA-seq) from TRA-1-60 (+) cells exhibited the
chimeric transcripts of ABHD12B, HHLA1, C4ORF51, and
lincRNA-RoR with LTR7 sequences that meant transcription
from intragenic LTR7s of HERV-Hs (Fig. 2C) (3, 10). Single-
cell quantitative RT-PCR (qRT-PCR) showed that virtually all
TRA-1-60 (+) cells—but not human dermal fibroblasts (HDFs)
or ESCs—expressed the DD-iPSC marker genes related to
HERV-H LTR7s (Fig. 2D). Furthermore, in both TRA-1-60 (+)
intermediate cells on day 20 and DD-iPSCs, we observed less
CpG dinucleotide methylation and more trimethylation of
lysine 4 on histone H3 (H3K4me3) in the LTR7-driven DD-iPSC
marker genes (Fig. 2E). LTR7-driven DD-iPSC marker genes
were highly expressed in TRA-1-60 (+) cells derived from HDFs
as well as from adipose tissue-derived mesenchymal stem cells
(mesoderm), astrocytes (ectoderm), and bronchial epithelium
(endoderm) (Fig. S3). Furthermore, we found that on days 21
and 29, TRA-1-60 (+) cells showed defective neural differenti-
ation, in that they still contained TRA-1-60 (+) cells even after
in vitro directed neural differentiation (Fig. 2F). Overall, these
data show that DD-iPSC clones are similar to TRA-1-60 (+) in-
termediate reprogrammed cells in both gene expression and neural
differentiation ability.
Genome-Wide LTR7 Activation During Reprogramming. This last
observation prompted us to examine the genome-wide LTR7
activity during reprogramming. qRT-PCR using a primer set for
a conserved sequence of HERV-H LTR7 (13, 14) revealed that
HERV-H transcripts transiently increased in TRA-1-60 (+) cells
during reprogramming (Fig. 3A). The expression level of HERV-H
in TRA-1-60 (+) intermediates on day 7 was significantly higher
than those in TRA-1-60 (−) cells (Fig. 3B). RNA-seq showed
that more than 40% of 3,771 LTR7 members in the human





















































































































Fig. 3. Transient hyperactivation of LTR7s during iPSC generation. (A)
Transition of total LTR7 transcription level during reprogramming. The plot
shows the relative expression of total HERV-H in intermediate reprogrammed
cells [EGFP (+) cells on day 3 and TRA-1-60 (+) cells on days 7–49] and normal
iPSCs (N) compared with HDFs (day 0) revealed by qRT-PCR. Each value was
normalized to that of G3PDH. n = 3. Error bars are SD. *P < 0.05 vs. HDF was
calculated by Dunnett test. (B) Abundant HERV-H expression in TRA-1-60 (+)
intermediates. Shown are relative expression of HERV-H in HDFs, TRA-1-60
(−) or (+) cells on day 7 and normal iPSCs analyzed by qRT-PCR. Each value
was normalized to that of G3PDH. n = 3. Error bars are SD. *P < 0.05 was
calculated by t test. (C) Expression patterns of the LTR7 family during
reprogramming. Data are shown as LTR7 members and LINE-1 reads per
kilobase of exon per million mapped reads (RPKM) in HDFs, TRA-1-60 (+)
cells on day 20, and ESCs/normal iPSCs (n = 8). (D) Distribution of CpG
methylation during reprogramming. The box plots show the distribution of
methylation level at CpGs on all probes (Left), LTR7 (Center), and LINE-1
(Right) regions with overhang sequences (250 bp) in HDFs (day 0), in-
termediate reprogrammed cells [EGFP (+) cells on d3 and TRA-1-60 (+) cells
on days 7–49], ESCs, and normal iPSCs. Red and black bars indicate the me-
dian and quartile, respectively. n = 3. Post hoc pairwise comparisons were
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Fig. 4. Role of OSK in LTR7 activation. (A) OSK is required for activation of
ABHD12B expression. Relative expression level of ABHD12B on day 7 post-
transduction for all combinations of OSKM. Error bars are SDs. n = 3. *P < 0.05
vs. Mock was calculated by Dunnett test. (B) Distribution of reprogramming
factor occupancy on all LTR7s loci revealed by ChIP-seq. (C) Significance of the
interaction of reprogramming factors to LTR7s. Histograms show counts of
peaks for OCT3/4, SOX2, or KLF4 overlapped with randomly selected regions
(10,000 random trials). The 95th percentile count of distribution is marked by
red lines. Green dots show counts of ChIP-seq peaks on LTR7 regions with
overhang sequences (250 bp). (D) GSEA plot showing enrichment of OSK oc-
cupancies in expressed LTR7s. Expressed LTR7 family members in TRA-1-60 (+)
cells on day 15 are enriched in the set of LTR7s that show full-array OSK binding
(P = 2.4e-155). (E ) KLF4-dependent binding of OCT3/4 and SOX2 to LTR7s.
Bars show the percentage of OCT3/4- or SOX2-bound LTR7 family members
and LINE-1 in HDFs transduced with OSKM (closed) or OSM (open) on day 3
posttransduction. χ2 tests were performed between the proportions (*P < 0.05).
(F ) Interaction between HERV-H loci and chromatin modifiers. ChIP assays
were performed to analyze the interaction of ABHD12B and HHLA1 loci
with KAP-1, ESET, p300, and pan-acetyl histone H3 (H3ac) occupancy in HDFs
transduced with OSM, OSKM, or OSNM on day 3 were analyzed by ChIP-qPCR.
n = 3. Error bars are SD.
12428 | www.pnas.org/cgi/doi/10.1073/pnas.1413299111 Ohnuki et al.
genome were transiently activated in TRA-1-60 (+) intermediate
reprogrammed cells (Fig. 3C), whereas another transposable
element, long-interspersed element-1 (LINE-1), showed varying
expression patterns. Array-based analyses revealed that CpG
methylation of LTR7 regions in TRA-1-60 (+) cells transiently
decreased (Fig. 3D) (15). In contrast, global CpGs and those
around LINE-1 elements gradually became methylated during
reprogramming. Therefore, LTR7s were activated in a genome-
wide manner during OSKM-mediated reprogramming.
Role of OSK in LTR7 Activation.We next examined how OSKM helps
activate the LTR7s during reprogramming. In day 7-transduced
HDFs, we found that forced expression of OSK or OSKM, but
not any single reprogramming factor or another combination,
induced expression of the LTR7-driven gene ABHD12B (Fig.
4A). Thus, OCT3/4, SOX2, and KLF4 are all required for LTR7
activation. ChIP and sequencing (ChIP-seq) analyses showed
that ∼15% of 3,771 LTR7s had cobinding of OCT3/4, SOX2, and
KLF4 (OSK), ∼8% had cobinding of OCT3/4 and KLF4 (OK),
and ∼5% had binding of KLF4 alone (K) (Fig. 4B). Compared
with random binding, the concentrations of OCT3/4, SOX2, or
KLF4 binding in LTR7s was highly significant (Fig. 4C). In addi-
tion, GSEA exhibited a significant correlation between OSK
binding and HERV-H LTR7 expression in TRA-1-60 (+) cells
(enrichment score = 0.85, P = 2.4 × 10−155) (Fig. 4D). The number
of OCT3/4- and SOX2-bound LTR7s markedly decreased in the
absence of KLF4 (P = 2.2 × 10−16 for both OCT3/4 and SOX2)
(Fig. 4E), but such drastic decreases were not observed in OCT3/4-
or SOX2-binding to LINE-1. Two proteins, KAP-1 (KRAB-
associated protein 1) and histone methyltransferase SET domain
bifurcated 1 (ESET), have been shown to be critical in suppression
of endogenous retroviruses (16). ChIP experiments revealed that
in HDFs transduced with OSKM, the binding of KAP-1 to LTR7s
significantly decreased in ABHD12B and HHLA1 loci, but this
decrease was not observed with OSM or OSNM (OSM with
NANOG instead of KLF4) (Fig. 4F). In addition, the interaction
between p300 and acetylated histone H3 was enriched by OSKM
transduction, but not when KLF4 was absent (Fig. 4F). Therefore,
KLF4 activates LTR7s by promoting OSK binding, recruiting the
coactivator p300, and excluding KAP-1.
KLF4, a DD-iPSC Marker, Activates LTR7. In addition to LTR7-driven
transcripts, we identified KLF4 as a marker gene associated with
the DD phenotype (Fig. 1D). Among the OSKM reprogramming
factors, only KLF4 was enriched in DD-iPSC subclones (Fig.
5A). Whether KLF4 expression was derived from transgene or
endogenous locus differed among clones (Fig. S4A). In the
subclones derived from TIG118-4F1 and 451F3, the expression
of endogenous KLF4 highly correlated to the DD phonotype
(Fig. S4B). On the other hand, there was no significant corre-
lation between neural differentiation potentials and endogenous
KLF4 expression in the subclones derived from TIG108-4F3 and
TKCBV5-6, which mainly expressed exogenous KLF4 (Fig.
S4B). These data suggest that KLF4 expression including both
aberrant activation of endogenous genes and insufficient si-
lencing of retroviral vectors could be associated with the DD
phenotype. We therefore analyzed the expression of KLF4, to-
gether with the remaining reprogramming factors, during iPSC
generation. Total expression levels of OCT3/4 and SOX2 (from
both endogenous genes and transgenes) increased more than
1,000-fold within 3 d after retroviral transduction and ap-
proached the levels in ESCs/iPSCs (Fig. 5B). After retroviral
transgenes were silenced, the expression of OCT3/4 and SOX2
remained high because the endogenous genes were induced. Con-
versely, overexpression of KLF4 was transient and decreased once
the retroviral transgenes were silenced (Fig. 5 A and B). Accord-
ingly, the copy number of KLF4 mRNA was less than 1/40 of those
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Fig. 5. Role of KLF4 in the DD phenotype. (A) High expression of KLF4 in DD-iPSCs. Expression levels of total OCT3/4, SOX2, KLF4, and c-MYC in normal- (N; n =
18) and DD- (D; n = 37) iPSC primary subclones in microarray analysis. *FDR < 0.05 vs. N was calculated by t test. (B) Relative expression of total OSKM in
intermediate reprogrammed cells were quantified by qRT-PCR and compared with those in iPSC. Each value was normalized to that of G3PDH. n = 3. Error bars
are SDs. *P < 0.05 vs. iPSC (N) was calculated by Dunnett test. (C) Copy number of OSKMmRNAs in iPSCs. Data are shown as copy numbers of mRNA per 50 ng of
total RNA calculated using a plasmid encoding each factor as a standard in qRT-PCR. n = 23. Error bars are SDs. (D) Expression of KLF4 protein. Western blot
analyses of expression of OCT3/4, SOX2, KLF4, c-MYC, and β-ACTIN proteins in DD-iPSCs (D) and normal iPSCs (N) transduced with Dox-inducible KLF4 main-
tained with (+) or without (−) Dox. (E) KLF4 induces DD-iPSC marker expression in iPSCs. Bars show the relative expression levels of ABHD12B, HHLA1, C4ORF51,
lincRNA-RoR, NANOG, and KLF4 in KLF4-overexpressing iPSCs analyzed by qRT-PCR. Each value was normalized to that of G3PDH. n = 3. Error bars are SDs. *P <
0.05 vs. Dox (−) were calculated by t test. (F) KLF4 prevents neural differentiation. Normal iPSCs transduced with Dox-inducible KLF4 were differentiated into
neural cells using the SFEBq method with (+) or without (−) Dox. Bars show the percentages of TRA-1-60 (+) cells after a SFEBq neural inducing culture for 14 d.
N and D represent normal and DD-iPSCs, respectively. n = 3. Error bars are SDs. *P < 0.05 was calculated by t test. (G) KLF4 changes the fate of iPSCs. PCA of
microarray data from HDFs (day 0), TRA-1-60 (+) intermediate reprogrammed cells, normal iPSC subclones (N), DD-iPSC subclones (D), and Dox-inducible KLF4-
transduced iPSCs with (+) or without (−) Dox for the 144 DD-iPSC marker genes. The green arrow indicates the route of reprogramming. The red broken arrow
indicates the fate transition after induction of the KLF4 transgene.








fact develops the transient increase of KLF4 expression during
reprogramming toward iPSCs. On the other hand, the expression of
OCT3/4 and SOX2 are constant even after transgene silencing
occurred between days 15 and 20 posttransduction. Overall, in-
creased expression of KLF4 correlated with aberrant activation of
LTR7s in both the reprogramming process and in DD-iPSCs.
To further examine the role of KLF4 in LTR7 activation, we
introduced a doxycycline (Dox)-inducible KLF4 expression cassette
into normal iPSCs using a PiggyBac transposon system (17) (Fig.
5D). Dox-induced KLF4 expression activated the LTR7-related
transcripts ABHD12B, HHLA1, C4ORF51, and lincRNA-RoR
but did not affect non-LTR–related genes, such as NANOG
(Fig. 5E). Furthermore, overexpression of KLF4 in normal iPSCs
produced the DD phenotype (Fig. 5F) (18). In contrast to neural
lineage commitment, we observed no effects of KLF4 on the
differentiation potentials of iPSCs into EN, ME, and PSMN
(Fig. S5). This tendency was common between DD-iPSCs and
KLF4-overexpressing iPSCs. PCA on the 144 DD-iPSC markers
showed that KLF4-overexpressing iPSCs are quite similar to
TRA-1-60 (+) intermediate reprogrammed cells (Fig. 5G), which
confirms that KLF4 helps establish the DD phenotype.
To clarify the specificity by which KLF4 activates HERV-Hs in
HDFs, we replaced KLF4 in the OSKM induction mixture with
the reprogramming factor NANOG (referred to as OSNM).
OSNM induced a few TRA1-60 (+) cells on day 7 and ESC-like
colonies on day 28 (Fig. S6A). In TRA-1-60 (+) cells induced by
OSNM, the expressions of KLF4 (Fig. S6B), HERV-Hs (Fig.
S6C), and LTR7-driven genes (Fig. S6D) were only slightly ac-
tivated. Therefore, overexpression of KLF4 and hyperactivation
of HERV-H LTR7s are strongly correlated with efficient
reprogramming in iPSC generation.
We next performed loss-of-function experiments to further in-
vestigate the roles of KLF4 and LTR7 in reprogramming and the
DD phenotype. We designed four sets of short hairpin RNAs
(shRNAs): one targeted KLF4 (shKLF4); two targeted LTR7
sequences conserved among ABHD12B, HHLA1, C4ORF51, and
lincRNA-RoR (shLTR7-1 and shLTR7-2); and one targeted
lincRNA-RoR (shRoR). In DD-iPSCs, shKLF4 and shLTR7-1, but
not shRoR, significantly suppressed the total expression of
HERV-Hs (Fig. 6A). The two shRNAs targeting the conserved
LTR7 sequences effectively suppressed ABHD12B, HHLA1,
C4ORF51, and lincRNA-RoR, but did not suppress NANOG (Fig.
6B). shRoR specifically repressed lincRNA-RoR expression but
did not affect ABHD12B, HHLA1, C4ORF51, or NANOG (Fig.
6B). Suppressing KLF4 or HERV-H LTR7s in DD-iPSCs effec-
tively reversed the DD phenotype and made the cells comparable
to normal iPSCs (Fig. 6C). We observed a similar trend for
shRoR, but the change was not statistically significant (P = 0.09).
In addition, shLTR7-1 canceled the DD phenotype of KLF4-
overexpressing iPSCs (Fig. 6D). Transducing these shRNAs with
OSKM reduced the number of TRA-1-60 (+) cells on days 7 and
11 (Fig. 6E) and almost completely inhibited the generation of
iPSC colonies (Fig. 6F). These data confirmed the important roles
of KLF4 and LTR7 in reprogramming and the DD phenotype.
Discussion
In this study, we found that genome-wide HERV-Hs, including
lincRNA-RoR, are transiently hyperactivated during reprogram-
ming toward iPSCs and play important roles in this process.
However, when reprogramming is complete and cells acquire full
pluripotency, HERV-H LTR7 activity should decrease to levels
comparable with those in ESCs. Failure to resilence this activity
leads to the DD phenotype. This observation resembles NANOG,
which promotes induction and maintenance of pluripotency, but
suppress differentiation when aberrantly expressed (19). We also
found that during reprogramming, OSK factors bind to and
activate LTR7s. Therefore, a major mechanism by which OSK
reprogramming factors promote human iPSC generation is by
transiently hyperactivating HERV-H LTR7s. Noteworthy, our
findings suggest the significance of the transition state of inter-
mediate reprogrammed cells, including hyperactivation of HERV-Hs
induced by reprogramming factors. Among these cells, KLF4
particularly plays important roles for the activation of HERV-
Hs. Our data also revealed that NANOG as a replacer of KLF4
in iPSC generation can induce less HERV-H activity during
reprogramming (11). Therefore, the reason why the significant
difference of reprogramming activity between KLF4 and NANOG
can be explained with our data.
Recent study by Lu et al. showed that HERV-H activity reg-
ulated by OCT3/4 and p300 is important for generation and self-
renewal of iPSCs (20). Among OSKM reprogramming factors, we
showed that KLF4 levels are the most important for activating and
resuppressing LTR7s. First, the binding of OCT3/4 and SOX2 to
LTR7s was highly dependent on the presence of KLF4. Corrob-
orating this finding, we and others have previously demonstrated
that the KLF4 protein binds to OCT3/4 and SOX2 proteins.
Second, we detected a surge in KLF4 expression during reprog-
ramming, which was correlated with the transient hyperactivation


































































































































































































Fig. 6. Loss of function experiments to test roles of KLF4 and LTR7s in
reprogramming and the DD phenotype. (A) KLF4 is responsible for HERV-H
expression. Shown are relative expressions of HERV-H in DD-iPSCs (D) trans-
duced with KLF4 shRNA (shKLF4), LTR7 shRNA-1 (shLTR7-1), or shRoR, and
normal iPSCs (N) compared with those of Mock-transduced DD-iPSCs. Each
value was normalized to that of G3PDH. n = 3. Error bars are SDs. n = 3. *P <
0.05 vs. Mock was calculated by Dunnett test. (B) Knockdown of LTR7 ex-
pression. Bars show relative expression of ABHD12B, HHLA1, C4ORF51,
lincRNA-RoR, and NANOG in normal iPSCs (N) and DD-iPSCs (D) transduced
with empty vector (Mock), LTR7 shRNA-encoding vectors (shLTR7-1 and -2), or
shRoR compared with Mock analyzed by microarray. Error bars are SDs. N =2.
*P < 0.05 vs. Mock was calculated by Dunnett test. (C) Suppression of KLF4/
HERV-H LTR7 rescues the DD phenotype. Shown are the relative proportions of
residual TRA-1-60 (+) cells on day 14 after neural differentiation of DD-iPSCs
(D) carrying empty vector (Mock), LTR7 shRNAs (shLTR7-1), or shRoR, compared
with normal iPSCs (N). n = 3. *P < 0.05 vs. Mock was calculated by Dunnett test.
(D) Suppression of LTR7 rescues the KLF4-induced DD phenotype. Shown are
the percentages of residual TRA-1-60 (+) cells on day 14 after neural differ-
entiation of normal iPSCs carrying dox-inducible KLF4, and empty vector or
LTR7 shRNA (shLTR7-1). Differentiation was performed in the presence (+) or
absence (−) of Dox. Error bars are SDs. n = 2. (E) LTR7 activity enhances
reprogramming efficiency. Shown are the percentages of TRA-1-60 (+) cells on
days 7 (black) and 11 (green) posttransduction of OSKM with empty vector
(Mock), LTR7 shRNA-encoding vectors (shLTR7-1 and -2), or shRoR vector. n = 3.
Error bars are SDs. *P < 0.05 vs. Mock was calculated by Dunnett test. (F) LTR7
activity facilitates iPSC generation. Shown are the relative numbers of iPSC
colonies on day 25 posttransduction of OSKM with empty vector (Mock), LTR7
shRNA-encoding vectors (shLTR7-1 and -2), or shRoR vector. Error bars are SDs.
n = 4. *P < 0.05 vs. Mock was calculated by Dunnett test.
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OSKM from retroviral transgenes is silenced. However, OCT3/4
and SOX2 maintained high expression levels because of the ac-
tivation of their endogenous genes. In contrast, the endogenous
KLF4 gene was only weakly activated, thus its total expression
level rapidly decreased. In DD-iPSC clones and subclones, KLF4
is expressed at higher levels than in normal iPSCs, in agreement
with the expression level of KLF4 helping determine LTR7 ac-
tivity. Furthermore, we found that KLF4, together with OCT3/4
and SOX2, increased the binding of coactivator p300 to LTR7s
and decreased KAP-1 binding to LTR7s. It has been shown that
both KLF4 and KAP-1 bind to methylated DNA (21), suggesting
a competition between the two proteins. Overall, we found that
KLF4 strongly promotes LTR7 activity.
Among LTR7-driven transcripts, we found that lincRNA-RoR
importantly influenced reprogramming and the DD phenotype.
This result is consistent with a report from Loewer et al., who
showed that lincRNA-RoR promoted iPSC generation (22). The
authors identified lincRNA-RoR as one of 10 lincRNAs whose
expression levels were higher in iPSCs than in ESCs (22). In
contrast, the levels of lincRNA-RoR within most iPSC clones in
our study were comparable to those of ESCs. Only DD-iPSCs
showed higher expression levels. The functions of lincRNA-RoR
remain elusive, but it may serve as a microRNA (miRNA)
sponge that protects SOX2 and NANOG from miRNA-mediated
degradation by sharing the binding sites of miRNAs that suppress
the core transcription factors (23). Alternatively, lincRNA-RoRmay
suppress p53 (24), which inhibits reprogramming (25–29). Other
LTR7-driven transcripts besides lincRNA-RoR likely also contrib-
ute to reprogramming and the DD phenotype, given that shRoR
only weakly reversed the DD phenotype compared with shKLF4 or
shLTR7s. Further studies, including genetic deletion of lincRNA-
RoR, are required to fully understand how the activation of LTR7s
contributes to reprogramming and the DD phenotype.
Our results suggest that reprogramming processes may use
unique transposable elements in each species. Because neither
HERV-H sequences nor lincRNA-RoR are conserved in mice,
their activation cannot contribute to mouse reprogramming.
Bourque and colleagues compared the binding sites of OCT3/4
and NANOG in their target genes and showed that species-
specific transposable elements have substantially altered the
transcriptional circuitry of pluripotent stem cells (6). Thus,
ERV-1, including HERV-H, plays a major role in reprogram-
ming human cells, whereas ERV-K, which is enriched in Oct3/4-
and Nanog-binding sites in mice (6), may be involved in re-
programming mouse cells. Another study showed that a small
portion of mouse ESCs and iPSCs express ERV-L retroviruses
and possess the ability to differentiate not only into embryonic
lineages but also into extraembryonic cells (30). Recently, Friedli
et al. showed that aberrant activation of intracisternal A particle,
a member of ERV-K, occurred during reprogramming of mouse
embryonic fibroblasts toward iPSCs, as well as HERV-H be-
havior in a human case, which may suggest the importance of
ERV activity in reprogramming beyond species (31). An im-
portant future task will involve examining the roles of species-
specific ERVs in reprogramming and pluripotency.
Materials and Methods
Detailed descriptions of materials and methods are available in SI Materials
and Methods. See Dataset S3 for primer sequences used in this study.
Plasmids are available from Addgene (www.addgene.org).
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SI Materials and Methods
Cell Culture.Human dermal fibroblasts (HDFs) obtained from the
Japanese Collection of Research Bioresources were maintained
in DMEM (Nacalai tesque) containing 10% FBS (Japan Bio-
serum) and 0.5% penicillin and streptomycin (Pen/Strep, Life
Technologies). PLAT-E (1) and PLAT-GP cells were main-
tained in the same medium. Embryonic stem cell (ESC) clones
obtained from WiCELL (H1 and H9) (2) and Kyoto University
(KhES1 and KhES3) (3) were maintained in Primate ESC me-
dium (ReproCELL) supplemented with 4 ng/mL recombinant
human basic fibroblast growth factor (bFGF, Wako) and 0.5%
Pen/Strep on mitomycin C (MMC)-treated SNL feeder cells, or
in mTeSR1 (Veritas) on Matrigel-coated plates (growth factor
reduced; BD Biosciences) (4).
Reprogramming. Reprogramming experiments were conducted
as described previously (4, 5). To generate retrovirus, we in-
troduced retroviral plasmids into PLAT-E or PLAT-GP cells
using the FuGENE 6 transfection reagent (Promega) (1). On the
following day, the medium was replaced with an equal volume of
fresh medium and cells were incubated overnight. The virus-
containing supernatant was collected, filtered through a 0.45-μm
pore-size cellulose acetate filter (Whatman) to remove cell de-
bris, and supplemented with 4 μg/mL Polybrene (Nacalai tes-
que). Appropriate combinations of viruses were mixed and
exposed to HDFs expressing the mouse Slc7a1 gene overnight.
This point was designated as day 0. To collect the samples on day
3 posttransduction, we introduced pMXs-internal ribosome entry
site-EGFP (IG) encoding SOX2 instead of pMXs-SOX2, along
with OKM (OCT3/4, KLF4, and c-MYC), and sorted EGFP (+)
cells by flow cytometry. TRA-1-60 (+) intermediate reprogrammed
cells were collected by magnetic activated cell sorting as described
previously. For reprogramming experiments with shRNA trans-
duction, 1 μg/mL puromycin was added to the medium from days
3–7 to eliminate untransduced cells. Cells were harvested on day 7
and reseeded onto MMC-inactivated SNL feeders to generate in-
duced pluripotent stem cells (iPSCs). On the following day, the
medium was replaced with Primate ESC medium supplemented
with 4 ng/mL bFGF, and the medium was then changed every
other day. The number of iPSC colonies was counted on day 25.
We distinguished bona fide iPSC colonies from non-iPSC colonies
based on their morphological differences (4).
Neural Differentiation and Flow Cytometry. The single-cell sus-
pensions of pluripotent stem cells were prepared using CTK
solution and AccuMAX (Innovative Cell Technology), and then
transferred at 9 × 103 cells per well of Lipidure-coated low-
binding 96-well plates (NOF Corporation) in 8GMK medium
consisting of Glasgow modified eagle medium (Life Technolo-
gies), 8% knockout serum replacement (Life Technologies), 1%
nonessential amino acids (NEAA; Life Technologies), 1% so-
dium pyruvate (Sigma), and 100 nM 2-mercaptoethanol (2-ME,
Life Technologies) supplemented with 500 nM A-83-01 (Stem-
gent) and 100 nM LDN193189 (Stemgent). The medium was
carefully half-changed on days 5, 8, and 11. On day 14, the ag-
gregates were collected to a 1.5-mL tube and pelletized by
centrifugation at 200 × g for 5 min. The pellet was washed with
PBS and then dispersed to single cells using AccuMAX, and then
cells were used for immunostaining. We used propidium iodide
(Life Technologies) or DAPI (Life Technologies) to distinguish
dead cells. Samples were analyzed using a FACS Aria II (Becton
Dickinson).
Primitive Streak-Like Mesendoderm Differentiation. Primitive streak-
like mesendoderm differentiation was performed as described
previously (6, 7). In brief, single-cell suspensions of human iPSCs
were plated onto fibronectin-coated plates (BD Biosciences) in
DMEM/F12 (Life Technologies) supplemented with 1% Insulin-
Transferrin-Selenite (Life Technologies), 1% Glutamax (Life
Technologies), 1% NEAA, 2% B27 (Life Technologies), 100 nM
2-ME, and 0.5% Pen/Strep. We added 3 μM CHIR99021
(Stemgent) and 50 ng/mL Activin A (Peprotech) on day 1, 3 μM
CHIR99021, 25 ng/mL Activin A and 20 ng/mL bFGF on day 2 and
3 μM CHIR99021, 10 ng/mL Activin A, 20 ng/mL bFGF and
40 ng/mL BMP4 (R&D Systems) on day 3.
Endoderm Differentiation. Endoderm differentiation was per-
formed as described previously, with slight modification (6, 8).
The single-cell suspensions of human pluripotent stem cells were
plated onto Matrigel-coated plates in RPMI1640 (Life Technolo-
gies) containing 2% B27, 100 ng/mL Activin A, 3 μM CHIR99021,
and 0.5% Pen/Strep. We added 0.5 mM sodium butyrate (Sigma)
on days 1–3, and then carried out sodium butyrate-free culture
until day 7.
Mesoderm Differentiation. The mesodermal differentiation was
performed as described previously, with slight modification (6, 9).
The single-cell suspensions of human pluripotent stem cells were
plated onto collagen I-coated plates (BD Biosciences) in DMEM/
F12 containing 2% B27, 100 ng/mL Activin A, 3 μM CHIR99021
and 0.5% Pen/Strep. Forty-eight hours later, the medium was re-
placed with DMEM/F12 supplemented with 2% B27, 25 ng/mL
BMP4, and 0.5% Pen/Strep. The medium was changed every other
day until day 8.
Antibodies.The following antibodies were used in the study: Alexa
488-conjugated TRA-1-60 (1:20, 560173, BD Biosciences), anti-
polysialylated neuronal cell-adhesion molecule (PSA-NCAM)
antibody (1:50; MAB5324, Millipore), APC-labeled anti–C-X-C
chemokine receptor type 4 (CXCR4) (1:5; FAB170A, R&D Sys-
tems), phycoerythrin (PE)-labeled antiplatelet-derived growth fac-
tor receptor-α (PDGFRA) (1:5; 556002, BD Pharmingen), APC-
conjugated anti-BRACHYURY (1:5; IC20851A, R&D Systems),
Alexa 647-conjugated anti-mouse IgM antibody (1:500; A-21238,
Life Technologies), PE-conjugated TRA-1–60 (1:5; 560193, BD
Pharmingen), and anti-PE microbeads (130-048-801, Miltenyi
Biotec). For Western blot analyses, we used anti-OCT3/4 (1:600;
sc-5279, Santa Cruz Biotechnology), anti-SOX2 (1:1,000; ab97959,
Abcam), anti-KLF4 (1:500; AF3640, R&D Systems), anti–c-MYC
(1:200; sc-42, Santa Cruz), anti–β-actin (1: 5,000; A5441, Sigma),
anti-mouse IgG HRP (1:3,000; 7076S, Cell Signaling Technology),
anti-rabbit IgG-HRP (1:2,000; 7074S, Cell Signaling), and anti-goat
IgG-HRP (1:2,000; sc-2056, Santa Cruz). For ChIP analyses, we
used anti-Flag M2 (F1804, Sigma), antitrimethylated lysine 4 of
histone H3 antibody (MABI0304, Wako), anti-p300 (sc-585,
Santa Cruz), anti-KAP1 (ab10483, Abcam), anti-SET domain
bifurcated 1 (sc-66884, Santa Cruz), and antihistone H3Ac (pan
acethyl) (39139, Active Motif).
Quantitative RT-PCR. Total RNA was isolated using the Qiazol
reagent (Qiagen) and a miRNeasy mini kit (Qiagen). CDNA was
generated with a ReverTra Ace-α kit (Toyobo) and oligo dT20
primer. For quantitative RT-PCR (qRT-PCR), reaction mixtures
were set up in triplicate using SYBR premix Ex-Taq II (Takara)
and run using a StepOne instrument (Applied Biosciences). The
levels of mRNA were normalized to G3PDH expression, and
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then relative expression was calculated as the fold-change from the
control. Primer sequences for each gene are shown in Dataset S3.
Gene-Expression Analysis by Microarray. Total RNA was purified
as described above and the quality was evaluated using a 2100
Bioanalyzer (Agilent Technologies). Total RNA (50 ng) was
labeled with cyanine 3-CTP and used for hybridization with
a SurePrint G3 Human GE 8 × 60 K array (G4851A, Agilent
Technologies) with a one-color protocol. Hybridized arrays were
scanned with a Microarray Scanner System (G2565BA, Agilent
Technologies), and extracted signals were analyzed using Gene-
Spring v12.6 software (Agilent Technologies). Gene-expression
values were normalized by 75th percentile shifts. Differentially ex-
pressed genes between normal and differentiation-defective (DD)-
iPSCs were extracted by comparison using t tests with Benjamini and
Hochberg corrections [FC > 2.0, false-discovery rate (FDR) < 0.05].
CpG Methylation Analysis by Microarray. Genomic DNA was
extracted using aDNeasy Blood and Tissue Kit (Qiagen). Purified
genomic DNA (30 ng) was used for bisulfite CT conversion with
an EZ DNA methylation kit (Zymo Research). Bisulfite-treated
DNA was whole-genome amplified and hybridized to Human-
Methylation450 BeadChip (Illumina), followed by labeling with
fluorescence by a single-base extension reaction. Fluorescent
signals were read on an Illumina BeadStation GX scanner.
Normalization and calculation of β-values, the ratio of methylated
to unmethylated cytosine, was performed using GenomeStudio
(Illumina). A β-value of 0 indicates nonmethylated cytosine, and
that of 1 indicates fully methylated cytosine. The relative distance
of the Infinium probe site from a region-of-interest, such as long-
terminal repeat 7 (LTR7) and long-interspersed element-1 (LINE-1),
was defined as the distance between the center of the region of
interest and the probe position.
Pyrosequencing. Genomic DNA was extracted using a DNeasy
Blood and Tissue Kit (Qiagen). Purified genomic DNA (500 ng)
was used for bisulfite CT conversion with an EZ DNA methyl-
ation kit (Zymo Research). PCR was performed in a 25-μL re-
action mixture containing 25 ng of bisulfite-converted DNA,
Pyromark PCR Master Mix (Qiagen), Coral Load Concentrate
(Qiagen), and 0.3 μM forward and 5′ biotinylated reverse pri-
mers. PCR conditions were 45 cycles at 95 °C for 30 s, 50 °C for
30 s, and 72 °C for 30 s The PCR product was bound to strep-
tavidin Sepharose beads (Amersham Biosciences) and then pu-
rified, washed, denatured, and washed again. Then, 0.3 μmol/L
pyrosequencing primer was annealed to the purified PCR product.
Pyrosequencing reactions were performed in the PSQ HS 96 Pyro-
sequencing System. The degree of methylation was expressed as
the percentage of methylated cytosines divided by the sum of
methylated and unmethylated cytosines. To validate the PCR
pyrosequencing assay, each CpG dinucleotide position was as-
sayed in triplicate and averages were used in the final analysis.
The primer sequences are shown in Dataset S3.
Plasmid Construction. To generate a doxycycline (Dox)-inducible
KLF4 expression vector, the KLF4 ORF was cloned into PB/TA/
ERN (10) using the Gateway LR reaction system (Life Tech-
nologies). Short hairpin RNA sequences were inserted into the
AgeI/EcoRI site of pMKO.1-puro (11) (Addgene). To generate a
shRNA expression vector for ESCs/iPSCs, a BglII/EcoRI frag-
ment of each shRNA construct was transferred into the BamHI/
MfeI site of PB/CAG-GIP/BP. All inserted fragments were veri-
fied by sequencing. Target sequences of shRNAs are as follows;
LTR7-1 (CCT GTT TGG TGG TCT CTT CAC), LTR7-2 (TGT
TTG GTG GTC TCT TCA CAC), long intergenic non-protein
coding RNA, regulator of reprogramming (lincRNA-RoR) (AAG
CCT GAG AGT TGG CAT GAA), and KLF4 (GAT CAA GCA
GGA GGC GGTC TC).
ChIP. For the ChIP assay of exogenous reprogramming factors,
such as OCT3/4, SOX2, and KLF4, 3× Flag-tagged factors or
nontagged factors were transduced into HDFs using a PLAT-E–
produced retroviral system. These cells were harvested at 3 d
posttransduction. Cells were fixed with 1% formaldehyde and
quenched with 125 mM glycine. Fixed cells were sequentially
treated with LB1 [50 mM Hepes-KOH, pH 7.5, 140 mM NaCl,
1 mM EDTA, 10% (wt/vol) glycerol, 0.5% Nonidet-P 40, and
0.25% TritonX-100], LB2 (10 mM Tris·HCl, pH 8.0, 200 mM
NaCl, 1 mM EDTA, and 0.5 mM EGTA), LB3 (10 mM Tris·HCl,
pH 8.0, 100 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, and 0.1%
sodium deoxycholate) to obtain nuclear extracts. Chromatin
samples were sheared by treatment with a Misonix Astrason S-
3000 sonicator (ON, 30 s; OFF, 1 min; Power, 7.0; 15 cycles). A
one-tenth volume of 10% (wt/vol) TritonX-100 solution was
added to the cell lysates to obtain cleared supernatants after
centrifugation. To reduce the nonspecific background, the
chromatin samples were incubated with normal IgG (Santa
Cruz) linked to Dynabeads (Life Technologies) for 30 min at 4 °
C. After removal of the beads, the cleared lysates were incubated
with a Dynabead-conjugated antibody overnight at 4 °C with
constant rotation. After incubation, the beads were washed twice
each with Wash buffer 1 (20 mM Tris·HCl, 8.0, 150 mM NaCl, 2
mM EDTA, 1% TritonX-100, and 0.1% SDS), wash buffer 2 (20
mM Tris·HCl, pH 8.0, 500 mM NaCl, 2 mM EDTA, 1% TritonX-
100, and 0.1% SDS), wash buffer 3 (10 mM Tris·HCl, pH 8.0, 250
mM lithium chloride, 1 mM EDTA, 1% Nonidet-P 40, and 1%
sodium deoxycholate), and TE buffer (10 mM Tris·HCl, pH 8.0
and 1 mM EDTA). The beads were then incubated with elution
buffer (25 mM Tris·HCl, pH 7.5, 5 mM EDTA, and 0.5% SDS)
supplemented with 0.4 mg/mL protease K (Nacalai tesque) at 42 °C
for 1 h and then at 65 °C overnight with constant rotation. Eluates
were purified using a Qiaquick PCR purification kit (Qiagen).
Multiplexed ChIP-seq libraries were prepared from 10 ng of
immunoprecipitated DNA fragments using NEBNext ChIP-seq
Library Prep Master Mix (New England BioLabs). For sequencing
using GAIIx (Illumina), cluster generation was performed using
TruSeq SR Cluster Kit v2 (Illumina). Each lane of flow cells
contained one sample. Sequencing was performed in single-read
runmodewith a total 76 cycles, including a 75-bp read and one cycle
for phasing. For sequencing using HiSeq2000 (Illumina), cluster
generation was performed using TruSeq SR Cluster Kit v3 (Illu-
mina) and six indexed libraries were loaded into each lane of flow
cells. Sequencing was performed in multiplexed single-read run
mode with total 86 cycles, including 6 cycles for reading the index
sequence. Peak call was executed using a model-based analysis of
the ChIP-seq algorithm (MACS) v1.4.0rc2 with default parameters.
RNA-Seq Library Preparation and Sequencing. DNase-treated RNA
(100 ng) was used to prepare individually indexed and strand-
specific RNA-seq libraries using a TruSeq Stranded Total RNA
sample prep kit (Illumina). Briefly, ribosomal RNA was depleted
using a Ribo-Zero Gold kit (AR Brown), followed by RNA
fragmentation, cDNA synthesis, end repair, A-base addition, and
ligation with Illumina-indexed adaptors. Cluster generation was
performed using a TruSeq PE cluster Kit v3 on an Illumina cBot
instrument. Six indexed libraries were loaded into each lane of
flow cells. Sequencing was performed on a Hiseq2000 in multi-
plexed paired-read runmode with a total of 208 cycles, including 6
cycles for reading the index sequence.
Data Analysis of Deep Sequencing. Conversion of Bcl into Fastq
format was achieved using the configureBclToFastq.pl program,
a part of CASAVA 1.8.2 (Illumina). Sequence reads were then
aligned to the human genome (GRCh37/hg19) using the paired-
end mode of the BWA v0.5.9rc1 and SAMtools v0.1.17 (ChIP-seq),
or TopHat2 software (RNA-seq). Aligned sequence tags were vi-
sualized using GenomeJack v2.1 (Mitsubishi Space Software).
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Quantitative Expression Analysis of Repeat Sequences. Repeat-
Masker open-3.3.0 (www.repeatmasker.org), a database of hu-
man repetitive sequences, was applied to reference sequences of
LTR7 and LINE-1. The LTR7 sequence was from LTR/endog-
enous retrovirus (ERV)-1 in the database, including LTR7,
LTR7A, LTR7B, LTR7C, and LTR7Y, and 3771 LTR7 regions
were found. The number of LINE-1 regions (LINE/L1 in the
database) was 979,568. For RNA-seq, the number of sequence
reads aligned with the LTR7-coding region by TopHat2 was
counted using the Partek Genomics Suite. Sample-to-sample
variation was normalized as follows: normalized number of se-
quence tags on LTR7 = number of reads aligned with the LTR7
region/total number of hg19-mappable sequence tags.
Single-Cell Expression Analysis. Single-cell suspensions prepared by
treatment with 0.25% trypsin/1 mM EDTA were incubated with
PE-conjugated TRA-1-60 and DAPI. TRA-1-60 (+)/DAPI (−)
cells were directly sorted into PCR master mix using the FACS
Aria II. The template for single-cell PCR was prepared using
CellsDirect reagent (Life Technologies). Preamplification of the
target sequences was performed for 22 cycles. Subsequent PCR
and data collection were conducted with a Biomark system (Flu-
idigm). Each sample was validated based on expression ofG3PDH
or ACTB, with a Ct value < 15. Ct values > 26 were taken to
indicate no expression and were unified as 100 for calculation of
ΔCt. We used following Taqman assays; abhydrolase domain
containing 12B (ABHD12B) (Hs00997975_g1), HERV-H LTR-
associating 1 (HHLA1) (Hs00903176_g1) and chromosome 4
open reading frame 51 (C4ORF51) (Hs03037752_m1).
Southern Blotting. Genomic DNA (3–5 μg) was digested with
restriction enzymes overnight. Digested DNA were separated
on a 0.8% agarose gel and transferred to a nylon membrane
(Amersham Biosciences). The membrane was incubated with
digoxigenin (DIG)-labeled DNA probe in DIG Easy Hyb buffer
(Roche) at 42 °C overnight with constant rotation. After washing,
alkaline phosphatase-conjugated anti-DIG antibody (1:10,000;
Roche) was added to the membrane. Signals were produced with
CDP-star reagent (Roche) and detected using a LAS3000 imag-
ing system (Fuji Film). Primer sequences for generation of probes
are shown in Dataset S3.
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Fig. S1. Subcloning of DD-iPSCs. (A) Monoclonal origin of iPSC subclones. The genomic DNA of the subclones derived from TKCBV5-6, TIG108-4F3, and TIG118-
4F1 by Southern blotting. Restriction enzymes and probes used for each clone are shown. For subclones derived from the 451F3 integration-free iPSC clone,
short tandem-repeat analyses were performed for 16 loci (D3S1358, TH01, D21S11, D18S51, Penta_E, D5S818, D13S317, D7S820, D16S539, CSF1PO, Penta_D,
AMEL, vWA, D8S1179, TPOX, and FGA). (B) Percentages of TRA-1-60 (+) cells 14 d after neural induction of each primary subclone and parental cells (P)
analyzed by flow cytometry. Blue and yellow circles indicate normal and DD-iPSC subclone, respectively. n = 2–3. Error bars are SDs.





























































































Fig. S2. Reproducibility of DD-iPSC related gene expression. Shown are the hierarchical clustering of 144 DD-iPSC marker expression in parental HDFs [day (d) 0],
intermediate reprogrammed cells at the indicated time points (days 3–49), ESCs, normal iPSCs, and DD-iPSCs.





















Fig. S3. The expression of DD-iPSC markers in TRA-1-60 (+) cells from various origins. Fold-increases of ABHD12B, HHLA1, C4ORF51, and lincRNA-RoR ex-
pression in TRA-1–60 (+) intermediate reprogrammed cells on day 28 compared with original somatic cell lines, determined by microarray. ASC, adipose tissue-








































































































Fig. S4. KLF4 transcripts in DD-iPSCs. (A) The histogram shows the representative transcription patterns of KLF4 in DD-iPSC primary subclones (PS), ESCs, and
HDFs analyzed by RNA-seq. Red and green box indicate protein coding region (common in transgene and endogenous locus) and untranslated region (only in
endogenous locus), respectively. (B) The relative expression of endogenous KLF4 in DD-iPSCs and their primary subclones (PS) compared with those in normal
iPSCs (N) analyzed qRT-PCR. Blue and yellow circles indicate normal and DD-iPSC subclones/parents, respectively. n = 3. Error bars are SDs.











































PSMN differentiation EN differentiation ME differentiation
Fig. S5. Differentiation potential of DD-iPSCs and KLF4-overexpressing iPSCs. Normal iPSCs (N), DD-iPSCs (D), and normal iPSCs transduced with Dox-inducible
KLF4 were differentiated into primitive streak-like mesendoderm (PSMN), endoderm (EN), or mesoderm (ME) in the conditions with (+) or without (–) Dox.
Closed bars in each graph represent the differentiation efficiencies into PSMN, EN, and ME evaluated by immunostaining with T, CXCR4, and PDGFRA, re-
















































































































































































































Fig. S6. The effect of exogenous NANOG homeobox (NANOG) on human ERV-H (HERV-H) activity. (A) Low reprogramming activity of NANOG. Shown are the
proportion of TRA-1-60 (+) cells on day 7 posttransduction of indicated factors (Left) and relative numbers of iPSC colonies counted on day 28 compared with
those induced by OCT3/4, SOX2, KLF4, and c-MYC (OSKM) (Right). Error bars are SD. n = 3. *P < 0.05 vs. OSKM was calculated by t test. (B) NANOG does not
enhance KLF4 expression. Shown are the relative expression of endogenous (Endo) and total KLF4 in HDFs, TRA-1-60 (+) cells induced by OSKM or OSNM (OSM
with NANOG instead of KLF4) on day 7, normal iPSCs (N), and ESCs compared with those in HDFs, revealed by qRT-PCR. Each value was normalized to that of
G3PDH. n = 3. Error bars are SD. *P < 0.05 vs. OSKM was calculated by t test. (C) Low activity of NANOG for HERV-H induction. Shown are the relative ex-
pression of HERV-H in HDFs, TRA-1-60 (+) cells induced by OSKM or OSNM on day 7, normal iPSCs (N), and ESCs compared with those in HDFs, revealed by qRT-
PCR. Each value was normalized to that of G3PDH, and then the value of Mock was adjusted to be 1. n = 3. Error bars are SD. *P < 0.05 vs. OSKM was calculated
by t test. (D) NANOG slightly enhanced the expression of LTR7-related genes. Shown are the relative expressions of LTR7-related genes ABHD12B and HHLA1 in
HDFs, TRA-1-60 (+) cells induced by OSKM or OSNM on day 7, normal iPSCs (N), and ESCs compared with those in HDFs, revealed by microarray. n = 3. Error bars
are SD. *FDR < 0.05 vs. OSKM was calculated by t test.
Dataset S1. Short tandem-repeat analyses of 451F3 subclones
Dataset S1
Shown are the results of short tandem-repeat analyses for 16 loci (D3S1358, TH01, D21S11, D18S51, Penta_E, D5S818, D13S317, D7S820, D16S539, CSF1PO,
Penta_D, AMEL, vWA, D8S1179, TPOX, and FGA) in 451F3 integration-free parental iPSCs (P) and its primary subclones (PS).
Dataset S2. DD-iPSC markers
Dataset S2
Microarray probes, genomic location, and gene symbols of DD-iPSC marker genes, P values and fold-change (FC) for comparison between normal and DD-
iPSC subclones.
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Dataset S3. Primer sequences used in the study
Dataset S3
The purposes, targets and sequences of primers used in this study are listed.
Ohnuki et al. www.pnas.org/cgi/content/short/1413299111 8 of 8
